
Country Origin, INDIA, Remidio
3 Reports in a single tap
World’s first offline AI for screening Diabetic Retinopathy, Glaucoma & AMD within few seconds.
Medios AI have been thoroughly validated across multiple clinical studies. Data has been published across multiple journals showcasing their superior performance.









